MRNA support zone 215 hit

Support zone: close above is a hit. Close on the level is a push. Graded on the regular-session close.

A support zone is a price below the market where a large amount of options positioning sits. The idea is that this positioning can slow a move down there, so the test is simple: does the stock close above it? When it was posted at 14:11 ET, MRNA traded at 219.93, 2.3% above the support zone. On the same map, the next level above was 232.5 and the next level below was 207.5. See the original post.

Price traded through the support zone during the session (first 5-minute close on the wrong side at 9:30 AM ET), with a low of 199.99 and a high of 225.00. In the last hour price moved up 4.11, from 220.89 to 225.00.

The regular-session close was 224.98, 9.98 (4.64%) above the support zone at 215. Under the rule (support zone: close above is a hit), that is a hit.

Moderna rejoined the Nasdaq-100 before the open, which required index funds to add shares, and a New York Times report described a planned NIH-backed public-private cancer-vaccine effort. The stock set a new 52-week high and closed at the day's high. MRNA finished the day up 14.2%, while SPY was up 0.6%.

• Investing.com: Why is Moderna stock surging today?
• Stocktwits: MRNA sets new 52-week high as Nasdaq-100 reentry meets NIH cancer-vaccine push
• The Motley Fool: Why Moderna stock surged today (Oct 9, 2026)